By: Mark SchreiberMark SchreibenMark SchraiberMedical News TodaySeptember 19, 2018 08:59:38Medical News today brings to you the first article in this series from the Medical News Today website.

This article examines the business model of two drugs that were discovered by a Canadian company and are now being used to help patients with chronic pain.

In the process, the researchers also reveal some of the challenges of clinical trials, and some of their successes and failures.

In this series, you’ll learn how the company and its investors came to be where they are today.

Read moreAbout Medical News today:Medical NewsToday is a leader in the medical news community with more than 1.3 billion daily unique visitors, and the most visited site in the world, with more people visiting its website every day than the United States, China, Germany and the United Kingdom combined.

The medical news site also serves as a conduit for the publication of research in the fields of health and medicine.

The company, Medical News Inc., is headquartered in Ottawa, Ontario, Canada, and is listed on the Toronto Stock Exchange under the ticker symbol MEDN.

Medical Newstoday.comMedical Newsnow.com is powered by our trusted editorial team, which has over 25 years of combined experience in covering the medical community, pharmaceutical industry, government and consumer products, and biotechnology.

In addition to our news team, we are also an active participant in the Canadian scientific community, working with industry partners and other partners to inform the public on developments in science and medicine and help the medical profession grow and advance.

Medical Newsnow, Inc. is a registered trademark of Medical News Corporation Canada.

[email protected] News, Today is an independent news service with an emphasis on healthcare and medicine, featuring content from leading Canadian health and medical publications and research journals.

For more information on our content, please visit our About Us page.